Breaking News Instant updates and real-time market news.

2021-12-06 07:09:59 ZETA Zeta Global $7.60 / -0.575 (-7.03%) 07:09 12/06/21 12/06 07:09 12/06/21 07:09	Zeta Global's Disqus, Akismet sign multi-year partnership to fight spam Akismet, an anti-spam product developed by Automattic, is announcing a multi-year partnership with Disqus. Akismet will continue to protect Disqus' entire network-which includes sites like ABC News, Rotten Tomatoes, and The Hill-from spam, as it has since 2014. This multi-year partnership enables the companies to better fight spam and test out new cutting-edge features.	10 Jun

2021-12-06 07:09:59

ZETA

Zeta Global

$7.60 / -0.575 (-7.03%)

07:09

12/06/21

12/06

07:09

12/06/21

07:09

Zeta Global's Disqus, Akismet sign multi-year partnership to fight spam

Akismet, an anti-spam product developed by Automattic, is announcing a multi-year partnership with Disqus. Akismet will continue to protect Disqus' entire network-which includes sites like ABC News, Rotten Tomatoes, and The Hill-from spam, as it has since 2014. This multi-year partnership enables the companies to better fight spam and test out new cutting-edge features.

10
Jun

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks	Foot Locker to divest team sales business » 07:33 06/27/22 06/27 07:33 06/27/22 07:33 FL Foot Locker $29.56 / +0.53 (+1.83%) Foot Locker announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FL Foot Locker $29.56 / +0.53 (+1.83%) 07:32 Today Foot Locker to divest team sales business 06/01/22 Foot Locker appoints Neil Bansal as Chief Strategy & Transformation Officer 05/20/22 Foot Locker rises 9.5% 05/20/22 Foot Locker sees FY22 comparable sales down 8%-10% FL Foot Locker $29.56 / +0.53 (+1.83%) 05/24/22 Williams Trading Foot Locker downgraded to Sell from Hold at Williams Trading 05/23/22 B. Riley Foot Locker price target lowered to $33 from $34 at B. Riley 05/23/22 Deutsche Bank Foot Locker price target raised to $32 from $30 at Deutsche Bank 05/23/22 Baird Foot Locker price target raised to $32 from $30 FL Foot Locker $29.56 / +0.53 (+1.83%) 05/20/22 Foot Locker backs FY22 EPS $4.25-$4.60, consensus $4.41 05/20/22 Foot Locker reports Q1 EPS $1.60, consensus $1.55 05/19/22 Notable companies reporting before tomorrow's open 05/19/22 Notable companies reporting before tomorrow's open FL Foot Locker $29.56 / +0.53 (+1.83%) 03/05/22 Foot Locker has gotten hit hard, stock looks like a buy, Barron's says 03/02/22 Fanatics valued at $27B in latest fundraising, WSJ reports FL Foot Locker $29.56 / +0.53 (+1.83%) 05/20/22 What You Missed On Wall Street On Friday 05/20/22 What You Missed On Wall Street This Morning 05/20/22 Fly Intel: Pre-market Movers 03/28/22 What You Missed On Wall Street On Monday 08/19/22 Foot Locker - FL FL Foot Locker $29.56 / +0.53 (+1.83%) 05/20/22 Unusually active option classes on open May 20th 04/20/22 Foot Locker call volume above normal and directionally bullish 03/04/22 Foot Locker put volume heavy and directionally bearish 02/23/22 Unusually active option classes on open February 23rd
Hot Stocks	Holley added to membership of the small-cap Russell 2000 Index » 07:33 06/27/22 06/27 07:33 06/27/22 07:33 HLLY Holley $10.21 / +0.21 (+2.10%) Holley was added as a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly HLLY Holley $10.21 / +0.21 (+2.10%) 04/20/22 Holley falls -9.9% 04/20/22 Holley falls -9.2% 04/20/22 Holley falls -8.0% 01/10/22 Holley completes acquisition of brands during Q4 for approximately $56M HLLY Holley $10.21 / +0.21 (+2.10%) 06/22/22 BofA Holley initiated with a Buy at BofA 03/04/22 Jefferies Holley assumed with a Buy rating, $20 price target at Jefferies 09/09/21 Truist Truist starts Holley at Buy with positive view of secular growth attributes 09/09/21 Truist Holley initiated with a Buy at Truist HLLY Holley $10.21 / +0.21 (+2.10%) 05/12/22 Holley reports Q1 EPS 18c, consensus 15c 04/19/22 Holley sees Q1 revenue $199M-$200M, consensus $180.6M 03/03/22 Holley sees FY22 revenue $765-$790M, consensus $718.69M 03/03/22 Holley reports Q4 EPS 8c consensus 12c 21 Apr HLLY Holley $10.21 / +0.21 (+2.10%) 06/22/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/19/22 Fly Intel: After-Hours Movers 03/04/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Hot Stocks	Digital World Acquisition says Garelick to resign from board » 07:32 06/27/22 06/27 07:32 06/27/22 07:32 DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Periodicals On The Fly Options DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) 07:31 Today Trump-linked SPAC Digital World reports receipt of grand jury subpoena 06/15/22 Digital World Acquisition working toward consummating combination w/ Trump Media 06/13/22 Digital World Acquisition says SEC recently issued further subpoena 05/18/22 Trump Media & Technology Group launches Truth Social Web App DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) 05/06/22 Truth Social CEO says Trump 'encouraged' Musk to buy Twitter, NYP reports 04/20/22 Digital World Acquisition named as short idea by Kerrisdale Capital 04/15/22 Fox News says didn't authorize account on Truth Social, Axios reports 04/12/22 Fox News is one of biggest brands to join Truth Social, Axios' Dan Primack says DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) 05/18/22 #SocialStocks: Musk and Twitter working to close $44B deal, despite noise 05/16/22 What You Missed On Wall Street On Monday 05/16/22 What You Missed On Wall Street This Morning 05/01/22 Week in SPAC News: Trump-linked SPAC in spotlight as Musk buys Twitter DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) 06/24/22 Largest borrow rate increases among liquid names 06/17/22 Digital World Acquisition Corp put volume heavy and directionally bearish 06/15/22 Unusually active option classes on open June 15th 06/13/22 Digital World Acquisition Corp put volume heavy and directionally bearish
Hot Stocks	Foot Locker to divest team sales business 07:32 06/27/22 06/27 07:32 06/27/22 07:32 FL Foot Locker $29.56 / +0.53 (+1.83%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FL Foot Locker $29.56 / +0.53 (+1.83%) 06/01/22 Foot Locker appoints Neil Bansal as Chief Strategy & Transformation Officer 05/20/22 Foot Locker rises 9.5% 05/20/22 Foot Locker sees FY22 comparable sales down 8%-10% 05/05/22 Foot Locker, Adidas announce new long-term strategic partnership FL Foot Locker $29.56 / +0.53 (+1.83%) 05/24/22 Williams Trading Foot Locker downgraded to Sell from Hold at Williams Trading 05/23/22 B. Riley Foot Locker price target lowered to $33 from $34 at B. Riley 05/23/22 Deutsche Bank Foot Locker price target raised to $32 from $30 at Deutsche Bank 05/23/22 Baird Foot Locker price target raised to $32 from $30 FL Foot Locker $29.56 / +0.53 (+1.83%) 05/20/22 Foot Locker backs FY22 EPS $4.25-$4.60, consensus $4.41 05/20/22 Foot Locker reports Q1 EPS $1.60, consensus $1.55 05/19/22 Notable companies reporting before tomorrow's open 05/19/22 Notable companies reporting before tomorrow's open FL Foot Locker $29.56 / +0.53 (+1.83%) 03/05/22 Foot Locker has gotten hit hard, stock looks like a buy, Barron's says 03/02/22 Fanatics valued at $27B in latest fundraising, WSJ reports FL Foot Locker $29.56 / +0.53 (+1.83%) 05/20/22 What You Missed On Wall Street On Friday 05/20/22 What You Missed On Wall Street This Morning 05/20/22 Fly Intel: Pre-market Movers 03/28/22 What You Missed On Wall Street On Monday 08/19/22 Foot Locker - FL FL Foot Locker $29.56 / +0.53 (+1.83%) 05/20/22 Unusually active option classes on open May 20th 04/20/22 Foot Locker call volume above normal and directionally bullish 03/04/22 Foot Locker put volume heavy and directionally bearish 02/23/22 Unusually active option classes on open February 23rd
Hot Stocks	Aptose Biosciences appoints Fletcher Payne as SVP, CFO » 07:32 06/27/22 06/27 07:32 06/27/22 07:32 APTO Aptose Biosciences / + Aptose Biosciences… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings APTO Aptose Biosciences / + 06/02/22 Aptose Biosciences presents highlights from corporate update, KOL event 05/04/22 Aptose Biosciences receives Fast Track designation for HM43239 04/13/22 iKena Oncology appoints Marango as CFO, Head of Corporate Development 04/07/22 Aptose Biosciences appoints Ledru as CCO, Marango to resign as CFO, CBO APTO Aptose Biosciences / + 04/28/22 Cantor Fitzgerald Aptose Biosciences assumed with an Overweight at Cantor Fitzgerald 12/20/21 Piper Sandler Aptose Biosciences price target lowered to $3 from $7 at Piper Sandler 12/20/21 H.C. Wainwright Aptose price target lowered to $12 from $14 at H.C. Wainwright 12/14/21 Alliance Global Partners Aptose price target lowered to $8 from $12 at Alliance Global Partners APTO Aptose Biosciences / + 05/09/22 Aptose Biosciences reports Q1 EPS (12c), consensus (15c)

Hot Stocks	Trump-linked SPAC Digital World reports receipt of grand jury subpoena » 07:31 06/27/22 06/27 07:31 06/27/22 07:31 DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Periodicals On The Fly Options DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) 06/15/22 Digital World Acquisition working toward consummating combination w/ Trump Media 06/13/22 Digital World Acquisition says SEC recently issued further subpoena 05/18/22 Trump Media & Technology Group launches Truth Social Web App 05/16/22 Trump 'generally obligated' to give TruthSocial six hour head start DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) 05/06/22 Truth Social CEO says Trump 'encouraged' Musk to buy Twitter, NYP reports 04/20/22 Digital World Acquisition named as short idea by Kerrisdale Capital 04/15/22 Fox News says didn't authorize account on Truth Social, Axios reports 04/12/22 Fox News is one of biggest brands to join Truth Social, Axios' Dan Primack says DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) 05/18/22 #SocialStocks: Musk and Twitter working to close $44B deal, despite noise 05/16/22 What You Missed On Wall Street On Monday 05/16/22 What You Missed On Wall Street This Morning 05/01/22 Week in SPAC News: Trump-linked SPAC in spotlight as Musk buys Twitter DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) 06/24/22 Largest borrow rate increases among liquid names 06/17/22 Digital World Acquisition Corp put volume heavy and directionally bearish 06/15/22 Unusually active option classes on open June 15th 06/13/22 Digital World Acquisition Corp put volume heavy and directionally bearish
Hot Stocks	nCino names Chris Ainsworth as chief people officer » 07:31 06/27/22 06/27 07:31 06/27/22 07:31 NCNO nCino $37.19 / +2.54 (+7.33%) nCino announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NCNO nCino $37.19 / +2.54 (+7.33%) 06/14/22 SimpleNexus announces Family First Funding has implemented Nexus Engagement 05/25/22 nCino announces AnnieMac completed rollout of Nexus Engagement, Origination 04/28/22 nCino selected by connectFirst to deploy its Banking Operating System 04/05/22 nCino's SimpleNexus announces Pinnacle Bank implemented Nexus Vision NCNO nCino $37.19 / +2.54 (+7.33%) 06/02/22 Truist nCino price target lowered to $70 from $80 at Truist 06/02/22 Needham nCino price target lowered to $42 from $60 at Needham 06/02/22 Barclays nCino price target raised to $39 from $38 at Barclays 06/02/22 KeyBanc nCino price target lowered to $45 from $60 at KeyBanc NCNO nCino $37.19 / +2.54 (+7.33%) 06/01/22 nCino sees FY23 EPS (30c)-(28c), consensus (32c) 06/01/22 nCino sees Q2 EPS (8c)-(9c), consensus (8c) 06/01/22 nCino reports Q1 EPS (6c), consensus (8c) 03/31/22 nCino reports Q4 EPS (9c), consensus (9c) NCNO nCino $37.19 / +2.54 (+7.33%) 04/04/22 nCino rumor mentioned in 'uncooked alert' by Betaville NCNO nCino $37.19 / +2.54 (+7.33%) 04/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/10/22 Fly Intel: After-Hours Movers NCNO nCino $37.19 / +2.54 (+7.33%) 06/01/22 nCino options imply 8.1% move in share price post-earnings 03/31/22 nCino options imply 10.8% move in share price post-earnings
Hot Stocks	Stealth BioTherapeutics Corporation (ADS) trading halted, news pending 07:28 06/27/22 06/27 07:28 06/27/22 07:28 MITO Stealth Biotherapeutics / + ShowHide Related Items >><< Company News Street Research MITO Stealth Biotherapeutics / + 06/14/22 Stealth Biotherapeutics to meet with FDA DCN to discuss NDA for Elamipretide 06/08/22 Stealth Biotherapeutics' SBT-272 shows motor neuron improvement in study 05/31/22 Stealth granted orphan drug designation for elamipretide by EMA 05/23/22 Stealth Biotherapeutics reports Phase 2 results of elamipretide in GA MITO Stealth Biotherapeutics / + 05/23/22 H.C. Wainwright Stealth Biotherapeutics price target lowered to $1.50 from $4 at H.C. Wainwright 07/01/21 Maxim Stealth Biotherapeutics initiated with a Buy at Maxim 07/01/21 Maxim Stealth Biotherapeutics initiated with a Buy at Maxim
Hot Stocks	Parsons to help modernize, expand Asheville regional airport » 07:27 06/27/22 06/27 07:27 06/27/22 07:27 PSN Parsons $40.43 / +2.1 (+5.48%) Parsons Corporation… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events PSN Parsons $40.43 / +2.1 (+5.48%) 06/21/22 Parsons appoints Tim Schmitt to executive leadership team 06/16/22 Parsons selected by DHA on $10B Omnibus IV contract 06/01/22 Parsons completes acquisition of Xator Corporation 05/26/22 Parsons awarded contract for AI-based smart mobility system PSN Parsons $40.43 / +2.1 (+5.48%) 04/22/22 Truist Parsons downgraded to Hold from Buy at Truist 03/17/22 Stifel Parsons resumed with a Buy at Stifel 03/11/22 BofA Parsons upgraded to Neutral from Underperform at BofA 03/11/22 BofA Parsons upgraded to Neutral from Underperform at BofA PSN Parsons $40.43 / +2.1 (+5.48%) 05/04/22 Parsons backs 2022 revenue view $3.7B-$3.9B, consensus $3.8B 05/04/22 Parsons reports Q1 adjusted EPS 40c, consensus 38c 02/23/22 Parsons sees 2022 revenue $3.7B-$3.9B, consensus $3.79B 02/23/22 Parsons reports Q4 adjusted EPS 55c, consensus 53c PSN Parsons $40.43 / +2.1 (+5.48%) 03/04/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/08/22 7th Annual Wells Fargo FinTech & Technology Services Forum
Recommendations	Blucora 'a most interesting,' under-the-radar idea, says Benchmark » 07:23 06/27/22 06/27 07:23 06/27/22 07:23 BCOR Blucora $18.43 / +0.72 (+4.07%) After having recently… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings BCOR Blucora $18.43 / +0.72 (+4.07%) 06/06/22 Avantax welcomes ATS Advanced Trustee Strategies 03/15/22 Engine Capital withdraws nomination of candidates for election to Blucora 02/17/22 Avantax acquires Gene Bell & Associates, terms not disclosed 02/14/22 Blucora issues statement in response to Engine Capital director nominations BCOR Blucora $18.43 / +0.72 (+4.07%) 05/04/22 Barrington Blucora weakness a buying opportunity, says Barrington 12/14/21 JPMorgan Blucora downgraded to Neutral from Overweight at JPMorgan 12/14/21 JPMorgan Blucora downgraded to Neutral from Overweight at JPMorgan 11/05/21 Barrington Blucora price target raised to $23 from $21 at Barrington BCOR Blucora $18.43 / +0.72 (+4.07%) 02/16/22 Blucora sees Q1 adjusted EPS $1.04-$1.52 , consensus $1.46 02/16/22 Blucora reports Q4 adjusted EPS (29c), consensus (45c)

Recommendations	CMS Energy price target lowered to $71 from $80 at BMO Capital » 07:22 06/27/22 06/27 07:22 06/27/22 07:22 CMS CMS Energy $65.16 / +1.03 (+1.61%) BMO Capital analyst James… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CMS CMS Energy $65.16 / +1.03 (+1.61%) 05/18/22 CMS Energy to add 300 megawatts of clean energy from two Michigan solar projects 05/09/22 Consumers Energy looks to work with landowners to identify power plant sites 04/20/22 CMS Energy, key stakeholders reach settlement agreement on Clean Energy Plan 02/01/22 Consumers Energy, General Motors announce clean energy pledge CMS CMS Energy $65.16 / +1.03 (+1.61%) 04/25/22 Credit Suisse CMS Energy initiated with a Neutral at Credit Suisse 04/21/22 Mizuho CMS Energy price target raised to $77 from $70 at Mizuho 04/19/22 Barclays CMS Energy downgraded to Equal Weight from Overweight at Barclays 04/07/22 KeyBanc CMS Energy downgraded to Sector Weight from Overweight at KeyBanc CMS CMS Energy $65.16 / +1.03 (+1.61%) 05/03/22 CMS Energy reaffirms FY22 adjusted EPS view $2.85-$2.89, consensus $2.87 05/03/22 CMS Energy reports Q1 EPS $1.21, consensus $1.12 02/03/22 CMS Energy raises 2022 adj EPS view to $2.85-$2.89 from $2.85-$2.87 02/03/22 CMS Energy reports Q4 cont-op EPS 40c, consensus 44c
Recommendations	DoorDash price target lowered to $100 from $140 at Needham » 07:19 06/27/22 06/27 07:19 06/27/22 07:19 DASH DoorDash $74.15 / +3.84 (+5.46%) Needham analyst Bernie… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options DASH DoorDash $74.15 / +3.84 (+5.46%) 06/13/22 DoorDash launches new app features to 'rate, review and discover' 06/08/22 Uber debuts Nationwide shipping, enables 'cross-country cravings' from US cities 05/20/22 DoorDash discloses $400M share repurchase program 05/16/22 Lone Pine adds TSMC in Q1, exits KE Holdings and Adobe DASH DoorDash $74.15 / +3.84 (+5.46%) 06/21/22 Goldman Sachs DoorDash reinstated with a Neutral at Goldman Sachs 06/06/22 Raymond James DoorDash initiated with a Market Perform at Raymond James 06/03/22 DA Davidson DoorDash price target lowered to $82 from $135 at DA Davidson 06/02/22 JMP Securities DoorDash price target lowered to $150 from $200 at JMP Securities DASH DoorDash $74.15 / +3.84 (+5.46%) 05/05/22 DoorDash reports Q1 EPS (48c), consensus (41c) 05/05/22 Notable companies reporting after market close 02/16/22 DoorDash reports Q4 EPS (45c), consensus (25c) 02/16/22 Notable companies reporting after market close 19 Aug DASH DoorDash $74.15 / +3.84 (+5.46%) 05/12/22 Instacart listing could happen as soon as this year, Bloomberg reports 03/23/22 Instacart plans to launch 15-minute grocery delivery service, Information says 03/17/22 Ride-hailing, delivery app drivers stretched amid spiking gas prices, NYT says 03/08/22 Uber, Lyft, others launch ad campaign to prevent unions, WSJ reports DASH DoorDash $74.15 / +3.84 (+5.46%) 06/25/22 Opening Day: Golden Sun rises in debut as Ivanhoe Electric delays IPO 06/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/11/22 Opening Day: EV-focused Phoenix Motor drops in market debut 06/06/22 What You Missed On Wall Street On Monday DASH DoorDash $74.15 / +3.84 (+5.46%) 06/01/22 DoorDash put volume heavy and directionally bearish 05/05/22 DoorDash options imply 13.1% move in share price post-earnings 05/05/22 Unusually active option classes on open May 5th 04/26/22 DoorDash put volume heavy and directionally bearish
Hot Stocks	Agrify enters New Zealand cannabis market with $1.625M Ora Pharm pact » 07:19 06/27/22 06/27 07:19 06/27/22 07:19 AGFY Agrify $2.22 / +0.12 (+5.71%) Agrify announced it has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly AGFY Agrify $2.22 / +0.12 (+5.71%) 06/01/22 Agrify announces launch of CannaBeast 13 short path 05/25/22 Agrify reminds stockholders to vote before proxy voting deadline 05/10/22 Agrify announces multimillion dollar engagement with Boone Labs 05/10/22 Agrify announces multimillion dollar engagement with Boone Labs AGFY Agrify $2.22 / +0.12 (+5.71%) 05/12/22 Alliance Global Partners Agrify price target lowered to $11 from $15 at Alliance Global Partners 03/25/22 Alliance Global Partners Agrify price target lowered to $15 from $32 at Alliance Global Partners 03/24/22 Maxim Agrify price target lowered to $12 from $40 at Maxim 03/23/22 Craig-Hallum Agrify downgraded to Hold at Craig-Hallum on covenant tripping risk AGFY Agrify $2.22 / +0.12 (+5.71%) 05/11/22 Agrify reports Q1 EPS (36c), consensus (33c) 03/23/22 Agrify sees FY22 revenue $140M-$142M, consensus $144.28M 03/23/22 Agrify reports Q4 EPS (60c), consensus (31c) 01/20/22 Agrify reaffirms Q4 revenue guidance of $26M-$28M, consensus $27.84M AGFY Agrify $2.22 / +0.12 (+5.71%) 03/23/22 Fly Intel: Pre-market Movers
Recommendations	Okta not seeing backlash from security breach, says William Blair » 07:18 06/27/22 06/27 07:18 06/27/22 07:18 OKTA Okta $101.20 / +7.8099 (+8.36%) , MSFT Microsoft $267.85 / +8.84 (+3.41%) William Blair analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options OKTA MSFT OKTA Okta $101.20 / +7.8099 (+8.36%) 06/02/22 Okta jumps 16% to $108.35 after raising fiscal year outlook 04/20/22 Okta says January breach lasted 25 minutes, impacted two customers 03/25/22 Okta does not consider January cyber incident 'to be material' 03/22/22 Microsoft says Lapsus$ stole source code through 'limited' access MSFT Microsoft $267.85 / +8.84 (+3.41%) 06/24/22 Ralph Lauren announces nomination of Cupp to board of directors 06/16/22 Square Enix says 'Final Fantasy 7 Rebirth' out next winter for PS5 06/16/22 Microsoft introduces Microsoft Defender for individuals 06/15/22 AvePoint adds Microsoft Azure backup to enhance data protection capabilities OKTA MSFT OKTA Okta $101.20 / +7.8099 (+8.36%) 06/03/22 Morgan Stanley Okta Q1 report should be 'clearing event,' says Morgan Stanley 06/03/22 DA Davidson Okta price target raised to $140 from $125 at DA Davidson 06/03/22 Oppenheimer Okta price target lowered to $170 from $210 at Oppenheimer 06/03/22 BTIG Okta price target lowered to $152 from $216 at BTIG MSFT Microsoft $267.85 / +8.84 (+3.41%) 06/24/22 Citi Citi names top software picks with sector de-rating 'mostly done' 06/17/22 Morgan Stanley Microsoft gaming build out hitting 'overdrive,' says Morgan Stanley 06/16/22 Credit Suisse Credit Suisse says Microsoft Azure growth opportunity not reflected in estimates 06/13/22 Jefferies Microsoft price target lowered to $320 from $325 at Jefferies OKTA MSFT OKTA Okta $101.20 / +7.8099 (+8.36%) 06/02/22 Okta raises FY23 adjusted EPS view to ($1.14)-($1.11), consensus ($1.25) 06/02/22 Okta sees Q2 adjusted EPS (32c)-(31c), consensus (33c) 06/02/22 Okta reports Q1 adjusted EPS (27c), consensus (34c) 06/02/22 Notable companies reporting after market close MSFT Microsoft $267.85 / +8.84 (+3.41%) 06/02/22 Microsoft lowers Q4 EPS view to $2.24-$2.32 from $2.28-$2.35, consensus $2.33 04/26/22 Microsoft sees Q4 productivity and business processes revenue $16.65B-$16.9B 04/26/22 Microsoft reports Q3 EPS $2.22 consensus $2.18 04/26/22 Notable companies reporting after market close OKTA MSFT OKTA Okta $101.20 / +7.8099 (+8.36%) 03/29/22 Okta slow to respond to Lapsus$ Hack, leaked details show, Wired reports 01/01/22 Amazon looks particularly attractive after wild year for tech, Barron's says MSFT Microsoft $267.85 / +8.84 (+3.41%) 06/23/22 Blizzard's 'Overwatch 2' to replace original 'Overwatch' live service, IGN says 06/23/22 Walmart reducing dependence on cloud giants with new capabilities, WSJ reports 06/22/22 Microsoft plans to do more to slow Russian propaganda, WaPo reports 06/21/22 Activision holders approve public harassment reporting proposal, WaPo says OKTA MSFT OKTA Okta $101.20 / +7.8099 (+8.36%) 06/03/22 What You Missed On Wall Street On Friday 06/03/22 What You Missed On Wall Street This Morning 06/03/22 Fly Intel: Pre-market Movers 06/02/22 Fly Intel: After-Hours Movers MSFT Microsoft $267.85 / +8.84 (+3.41%) 06/22/22 What You Missed This Week in Video Games 06/22/22 What You Missed On Wall Street This Morning 06/14/22 What You Missed This Week in Video Games 06/10/22 What You Missed On Wall Street This Morning OKTA MSFT OKTA Okta $101.20 / +7.8099 (+8.36%) 06/02/22 Okta options imply 8.8% move in share price post-earnings 03/22/22 Unusually active option classes on open March 22nd 02/18/22 Okta put volume heavy and directionally bearish 01/21/22 Okta put volume heavy and directionally bearish MSFT Microsoft $267.85 / +8.84 (+3.41%) 06/03/22 Unusually active option classes on open June 3rd 06/02/22 Unusually active option classes on open June 2nd 05/31/22 Microsoft call volume above normal and directionally bullish 05/02/22 Microsoft put buyer realizes 57% same-day gains
Hot Stocks	Capricor Therapeutics announces one-year results from HOPE-2 OLE study » 07:18 06/27/22 06/27 07:18 06/27/22 07:18 CAPR Capricor Therapeutics $4.52 / -0.03 (-0.66%) Capricor Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Options CAPR Capricor Therapeutics $4.52 / -0.03 (-0.66%) 05/25/22 Capricor Therapeutics appoints Avat as Chief Business Officer 03/28/22 Capricor Therapeutics reports results from Phase 2 INSPIRE study 03/11/22 Capricor Therapeutics publishes results from Phase 2 study of CAP-1002 03/02/22 Capricor Therapeutics appoints Paulson as VP of Clinical Development CAPR Capricor Therapeutics $4.52 / -0.03 (-0.66%) 01/31/22 H.C. Wainwright Capricor Therapeutics price target raised to $18 from $14 at H.C. Wainwright 10/11/21 H.C. Wainwright Capricor Therapeutics price target raised to $14 from $9 at H.C. Wainwright CAPR Capricor Therapeutics $4.52 / -0.03 (-0.66%) 03/10/22 Capricor Therapeutics options imply 18.1% move in share price post-earnings

Recommendations	CarMax price target raised to $105 from $90 at Wedbush » 07:16 06/27/22 06/27 07:16 06/27/22 07:16 KMX CarMax $98.44 / +6.68 (+7.28%) Wedbush analyst Seth… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options KMX CarMax $98.44 / +6.68 (+7.28%) 06/24/22 CarMax plans to open ten new locations in FY23 06/24/22 CarMax sold 427,257 units in Q1, down 5.5% from the prior year quarter 05/16/22 Tepper's Appaloosa buys two casinos in Q1, exits T-Mobile and GM 04/12/22 CarMax drops 5% to $98.05 after Q4 earnings miss estimates KMX CarMax $98.44 / +6.68 (+7.28%) 06:54 Today Baird CarMax valuation attractive for patient investors, says Baird 06/07/22 JPMorgan CarMax price target lowered to $105 from $110 at JPMorgan 05/16/22 Evercore ISI CarMax added to 'Tactical Outperform' list at Evercore ISI 05/02/22 Needham Needham starts CarMax at Hold amid increased spending on omni-channel strategy KMX CarMax $98.44 / +6.68 (+7.28%) 06/24/22 CarMax reports Q1 EPS $1.56, consensus $1.49 06/23/22 Notable companies reporting before tomorrow's open 06/23/22 Notable companies reporting before tomorrow's open 04/12/22 CarMax reports Q4 EPS 98c, consensus $1.25 KMX CarMax $98.44 / +6.68 (+7.28%) 02/26/22 Deere among quality companies doing business mostly in the U.S., Barron's says KMX CarMax $98.44 / +6.68 (+7.28%) 06/24/22 What You Missed On Wall Street On Friday 06/24/22 What You Missed On Wall Street This Morning 05/02/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/13/22 What You Missed On Wall Street On Wednesday 09/29/22 CarMax - KMX 06/28/22 CarMax Inc. KMX CarMax $98.44 / +6.68 (+7.28%) 04/12/22 Unusually active option classes on open April 12th
Hot Stocks	Frontier Group issues open letter to Spirit Airlines shareholders » 07:15 06/27/22 06/27 07:15 06/27/22 07:15 ULCC Frontier Group $10.53 / +0.655 (+6.64%) , SAVE Spirit Airlines $24.54 / +0.71 (+2.98%) Frontier Group (ULCC),… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ULCC SAVE ULCC Frontier Group $10.53 / +0.655 (+6.64%) 06/26/22 Fly Intel: Top five weekend stock stories 06/26/22 ISS recommends Spirit holders vote for amended merger agreement with Frontier 06/24/22 Spirit Airlines board says JetBlue's revised offer 'not a Superior Proposal' 06/24/22 Frontier Group raises Spirit Airlines deal consideration by $2.00 per share SAVE Spirit Airlines $24.54 / +0.71 (+2.98%) 06/26/22 Fly Intel: Top five weekend stock stories 06/26/22 ISS recommends Spirit holders vote for amended merger agreement with Frontier 06/24/22 Spirit Airlines board says JetBlue's revised offer 'not a Superior Proposal' 06/24/22 Frontier Group raises Spirit Airlines deal consideration by $2.00 per share ULCC SAVE ULCC Frontier Group $10.53 / +0.655 (+6.64%) 06/23/22 Raymond James Frontier Group upgraded to Outperform from Market Perform at Raymond James 06/10/22 JPMorgan Spirit Airlines upgraded to Overweight from Neutral at JPMorgan 04/11/22 MKM Partners JetBlue upgraded to Neutral at MKM Partners on valuation 04/06/22 MKM Partners MKM Partners expects to see 'heavy regulatory pushback' to JetBlue-Spirit deal SAVE Spirit Airlines $24.54 / +0.71 (+2.98%) 06/23/22 Raymond James Frontier Group upgraded to Outperform from Market Perform at Raymond James 06/10/22 JPMorgan Spirit Airlines upgraded to Overweight from Neutral at JPMorgan 05/05/22 Deutsche Bank Spirit Airlines price target lowered to $27 from $38 at Deutsche Bank 04/11/22 MKM Partners JetBlue upgraded to Neutral at MKM Partners on valuation ULCC SAVE ULCC Frontier Group $10.53 / +0.655 (+6.64%) 04/28/22 Frontier Group sees Q2 pre-tax margin between 1%-5% 04/28/22 Frontier Group reports Q1 EPS (56c), consensus (43c) 02/07/22 Frontier Group is not providing guidance 02/07/22 Frontier Group is not providing guidance SAVE Spirit Airlines $24.54 / +0.71 (+2.98%) 06/20/22 Fly Intel: Top five weekend stock stories 05/04/22 Spirit Airlines sees FY22 other capital expenditures $240M 05/04/22 Spirit Airlines sees Q2 adjusted operating expenses $1.355B-$1.365B 05/04/22 Spirit Airlines reports Q1 adjusted EPS ($1.60), consensus ($1.58) ULCC SAVE ULCC Frontier Group $10.53 / +0.655 (+6.64%) 04/05/22 JetBlue offers roughly $3.6B for Spirit Airlines, NY Times says SAVE Spirit Airlines $24.54 / +0.71 (+2.98%) 06/17/22 Buttigieg asks airlines to prepare for potentially busy summer, WSJ reports 06/10/22 CDC to lift negative test requirement to enter U.S., CNN reports 04/21/22 DOJ appeals transportation mask mandate ruling, NYT reports 04/20/22 CDC requests that DOJ appeal ruling to lift travel mask mandate, CNBC says ULCC SAVE ULCC Frontier Group $10.53 / +0.655 (+6.64%) 06/23/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/21/22 What You Missed On Wall Street On Tuesday 06/21/22 What You Missed On Wall Street This Morning 06/10/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations SAVE Spirit Airlines $24.54 / +0.71 (+2.98%) 06/23/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/21/22 What You Missed On Wall Street On Tuesday 06/21/22 What You Missed On Wall Street This Morning 06/21/22 Fly Intel: Pre-market Movers 06/30/22 Spirit Airlines, Inc. SAVE SAVE Spirit Airlines $24.54 / +0.71 (+2.98%) 06/24/22 Spirit Airlines call volume above normal and directionally bullish 05/16/22 Unusually active option classes on open May 16th 05/12/22 Spirit Airlines call volume above normal and directionally bullish 04/06/22 Unusually active option classes on open April 6th
Initiation	AXT Inc. initiated with a Buy at Needham » 07:15 06/27/22 06/27 07:15 06/27/22 07:15 AXTI AXT Inc. $6.22 / +0.27 (+4.54%) Needham analyst Charles… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings AXTI AXT Inc. $6.22 / +0.27 (+4.54%) 01/10/22 AXT Inc. announces formal application for subsidiary IPO on STAR Market AXTI AXT Inc. $6.22 / +0.27 (+4.54%) 04/29/22 Northland AXT Inc. price target lowered to $12 from $15 at Northland 04/29/22 B. Riley AXT Inc. price target lowered to $8 from $9.50 at B. Riley 11/04/21 Fly Intel: Top five analyst initiations 11/04/21 Wedbush AXT Inc. initiated with an Outperform at Wedbush AXTI AXT Inc. $6.22 / +0.27 (+4.54%) 04/28/22 AXT Inc. reports Q1 EPS 7c, consensus 6c 02/16/22 AXT Inc. sees FY22 revenue up 15%-20%, consensus $158.14M 02/16/22 AXT Inc. sees Q1 EPS 7c-9c, consensus 8c 02/16/22 AXT Inc. reports Q4 EPS 7c, consensus 6c
Recommendations	Xenon Pharmaceuticals price target lowered to $41 from $47 at Wedbush » 07:15 06/27/22 06/27 07:15 06/27/22 07:15 XENE Xenon Pharmaceuticals $30.97 / -0.73 (-2.30%) Wedbush analyst Laura… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events XENE Xenon Pharmaceuticals $30.97 / -0.73 (-2.30%) 06/22/22 Xenon provides update on additional data from XEN1101 program 06/21/22 Xenon Pharmaceuticals on track to initiate XEN1101 Phase 3 program in 2H22 05/03/22 Xenon Pharmaceuticals announces initiation of Phase 3 trial of XEN1101 01/19/22 Xenon Pharmaceuticals' flunarizine granted FDA orphan designation XENE Xenon Pharmaceuticals $30.97 / -0.73 (-2.30%) 11/11/21 SVB Leerink Xenon Pharmaceuticals price target raised to $40 from $34 at SVB Leerink 10/28/21 RBC Capital Xenon Pharmaceuticals initiated with an Outperform at RBC Capital 10/06/21 Wedbush Wedbush remains bullish on Xenon as financing gives firepower to advance XEN1101 10/04/21 Jefferies Jefferies ups Xenon target to $50 after 'home run' epilepsy data XENE Xenon Pharmaceuticals $30.97 / -0.73 (-2.30%) 05/10/22 Xenon Pharmaceuticals reports Q1 EPS (35c), consensus (41c) 23 Jun 06 Oct XENE Xenon Pharmaceuticals $30.97 / -0.73 (-2.30%) 06/23/22 What You Missed On Wall Street On Thursday 06/23/22 What You Missed On Wall Street This Morning 06/23/22 Fly Intel: Pre-market Movers 06/22/22 Fly Intel: After-Hours Movers 08/15/22 2022 Biotech Summer Summit
Hot Stocks	Akero Therapeutics presents analysis from Phase 2a BALANCED study » 07:13 06/27/22 06/27 07:13 06/27/22 07:13 AKRO Akero Therapeutics $10.34 / -0.36 (-3.36%) Akero Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly AKRO Akero Therapeutics $10.34 / -0.36 (-3.36%) 06/16/22 Akero Therapeutics announces two financing transactions for up to $125M 06/13/22 Akero Therapeutics to present keystone symposium on efruxifermin 05/06/22 Akero Therapeutics expects cash to fund operations into Q3 of 2023 02/25/22 Akero Therapeutics 'on track' to report HARMONY results in Q3 AKRO Akero Therapeutics $10.34 / -0.36 (-3.36%) 11/15/21 Canaccord Searching... price target raised to $49 from $46 at Canaccord 10/19/21 Fly Intel: Top five analyst downgrades 10/19/21 Morgan Stanley Akero Therapeutics assumed at Equal Weight from Overweight at Morgan Stanley 09/10/21 BofA Akero Therapeutics initiated with a Buy at BofA AKRO Akero Therapeutics $10.34 / -0.36 (-3.36%) 05/06/22 Akero Therapeutics reports Q1 EPS (74c), consensus (80c) 02/25/22 Akero Therapeutics reports Q4 EPS (93c), consensus (82c) AKRO Akero Therapeutics $10.34 / -0.36 (-3.36%) 05/08/22 Short Report: GitLab back in bears’ crosshairs 01/18/22 Fly Insider: Landec, AMC Entertainment among week's notable insider trades 12/31/21 Short Report: Krispy Kreme shorts capitulate

Hot Stocks	Aclaris Therapeutics appoints Gail Cawkwell, MD, PhD, as Chief Medical Officer » 07:13 06/27/22 06/27 07:13 06/27/22 07:13 ACRS Aclaris Therapeutics $14.41 / -1.44 (-9.09%) Aclaris… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings ACRS Aclaris Therapeutics $14.41 / -1.44 (-9.09%) 06/03/22 PDS Biotechnology appoints Brown as SVP, General Counsel 02/24/22 Aclaris Therapeutics expects cash to fund operations through end of 2024 02/01/22 Aclaris Therapeutics names James Loerop as Chief Business Officer 01/11/22 Aclaris Therapeutics falls after reporting Chief Medical Officer departed ACRS Aclaris Therapeutics $14.41 / -1.44 (-9.09%) 05/10/22 Piper Sandler Piper Sandler remains bullish on Aclaris Therapeutics after in-line Q1 update 12/07/21 Piper Sandler Piper Sandler remains bullish on Aclaris Therapeutics following R&D day 07/23/21 Jefferies Aclaris Therapeutics assumed with a Buy at Jefferies ACRS Aclaris Therapeutics $14.41 / -1.44 (-9.09%) 05/10/22 Aclaris Therapeutics reports Q1 EPS (31c), consensus (40c) 02/24/22 Aclaris Therapeutics reports Q4 EPS (37c), consensus (36c)
Recommendations	William Blair sees 'some likelihood of higher bids' for Zendesk » 07:12 06/27/22 06/27 07:12 06/27/22 07:12 ZEN Zendesk $74.05 / +16.03 (+27.63%) It is not out of the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options ZEN Zendesk $74.05 / +16.03 (+27.63%) 06/24/22 Zendesk rises 27.9% 06/24/22 Zendesk rises 29.0% 06/24/22 Zendesk rises 28.7% 06/24/22 Zendesk up 30% to $75.55 after agreeing to be acquired for $77.50 per share ZEN Zendesk $74.05 / +16.03 (+27.63%) 06/25/22 UBS Zendesk price target lowered to $77.50 from $128 at UBS 06/24/22 Stifel Stifel keeps Buy rating on Zendesk, doesn't see 'end of the road quite yet' 06/24/22 Canaccord Zendesk downgraded to Hold from Buy at Canaccord 06/24/22 Jefferies Competing Zendesk bid 'possible, but not probable,' says Jefferies ZEN Zendesk $74.05 / +16.03 (+27.63%) 04/28/22 Zendesk sees 2022 revenue $1.685B-$1.71B, consensus $1.69B 04/28/22 Zendesk sees Q2 revenue $402M-$408M, consensus $404.6M 04/28/22 Zendesk reports Q1 EPS 12c, consensus 14c 04/28/22 Notable companies reporting after market close ZEN Zendesk $74.05 / +16.03 (+27.63%) 06/23/22 Zendesk close to reaching deal with buyout firms, WSJ says 06/14/22 Zendesk in settlement discussions with Jana Partners, WSJ reports 06/08/22 Jana to sue Zendesk to set annual meeting date, Bloomberg reports 06/08/22 Zendesk buyout by PE suitors looking 'less likely,' CNBC's Faber says ZEN Zendesk $74.05 / +16.03 (+27.63%) 06/24/22 What You Missed On Wall Street On Friday 06/24/22 What You Missed On Wall Street This Morning 06/24/22 Fly Intel: Pre-market Movers 06/13/22 What You Missed On Wall Street On Monday ZEN Zendesk $74.05 / +16.03 (+27.63%) 06/24/22 Unusually active option classes on open June 24th 04/28/22 Zendesk options imply 6.2% move in share price post-earnings 04/27/22 Zendesk call volume above normal and directionally bullish 04/14/22 Zendesk call volume above normal and directionally bullish
Hot Stocks	Amryt Pharma appoints Tracy Cunningham as chief medical officer » 07:12 06/27/22 06/27 07:12 06/27/22 07:12 AMYT Amryt Pharma $7.22 / -0.11 (-1.50%) Amryt announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly AMYT Amryt Pharma $7.22 / -0.11 (-1.50%) 06/24/22 Amryt Pharma to pursue Formal Dispute Resolution for Oleogel-S10 NDA 06/23/22 Amryt Pharma announces EC approval of Filsuvez in the EU 06/13/22 Amryt Pharma presents clinical data from OLEs of Mycapssa trials 05/17/22 Amryt Pharma announces details of EMA Contingent Value Rights payment AMYT Amryt Pharma $7.22 / -0.11 (-1.50%) 03/10/22 H.C. Wainwright Amryt Pharma price target lowered to $18 from $20 at H.C. Wainwright 03/01/22 Maxim Amryt Pharma price target lowered to $18 from $27 at Maxim 03/01/22 Canaccord Amryt Pharma price target lowered to $19 from $40 at Canaccord 03/01/22 H.C. Wainwright Amryt Pharma price target lowered to $20 from $29 at H.C. Wainwright AMYT Amryt Pharma $7.22 / -0.11 (-1.50%) 05/04/22 Amryt Pharma reaffirms 2022 revenue $260M-$270M, consensus $269.26M 05/04/22 Amryt Pharma reports Q1 EPS (5c), consensus (2c) 03/09/22 Amryt Pharma sees 2022 revenue $260M-$270M, consensus $341.17M 03/09/22 Amryt Pharma reports Q4 EPS 7c, consensus (15c) AMYT Amryt Pharma $7.22 / -0.11 (-1.50%) 03/09/22 Fly Intel: Pre-market Movers
Hot Stocks	Precision BioSciences announces closing of underwritten offering of stock » 07:11 06/27/22 06/27 07:11 06/27/22 07:11 DTIL Precision BioSciences $1.47 / +0.01 (+0.68%) Precision BioSciences… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events DTIL Precision BioSciences $1.47 / +0.01 (+0.68%) 06/21/22 Precision BioSciences announces agreement with Novartis 06/08/22 Precision BioSciences provides update on allogeneic CAR T programs 05/18/22 Precision BioSciences publishes data from in vivo gene editing program 05/12/22 Precision BioSciences announces grant of inducement awards under Nasdaq rule DTIL Precision BioSciences $1.47 / +0.01 (+0.68%) 06/16/22 BMO Capital Precision BioSciences initiated with an Outperform at BMO Capital 06/09/22 William Blair Precision BioSciences downgraded to Market Perform at William Blair 12/13/21 BTIG Precision BioSciences price target raised to $20 from $16 at BTIG DTIL Precision BioSciences $1.47 / +0.01 (+0.68%) 05/09/22 Precision BioSciences reports Q1 EPS (46c), consensus (54c) 06/29/22 2022 Virtual Cell Therapy Summit
Hot Stocks	Eargo announces up to $125M strategic investment from Patient Square Capital » 07:10 06/27/22 06/27 07:10 06/27/22 07:10 EAR Eargo $1.25 / +0.07 (+5.93%) Eargo announced it has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Options EAR Eargo $1.25 / +0.07 (+5.93%) 05/31/22 Nasdaq confirms continued listing of Eargo stock 05/13/22 Eargo receives Nasdaq non-compliance letter 04/29/22 Eargo sees Q1 gross systems shipped 5,770 04/29/22 Eargo enters civil settlement agreement with U.S. DOJ EAR Eargo $1.25 / +0.07 (+5.93%) 09/23/21 Fly Intel: Top five analyst downgrades 09/23/21 William Blair William Blair downgrades Eargo on 'multiple unknowns' from criminal probe 09/23/21 Wells Fargo Wells Fargo cuts Eargo to Equal Weight, slashes price target $10 from $52 09/23/21 William Blair Eargo downgraded to Market Perform from Outperform at William Blair EAR Eargo $1.25 / +0.07 (+5.93%) 03/07/22 Eargo options imply 12.6% move in share price post-earnings 02/10/22 Eargo options imply 10.7% move in share price post-earnings 02/03/22 Eargo options imply 9.5% move in share price post-earnings 01/27/22 Eargo options imply 14.5% move in share price post-earnings

Events

Earnings calls, analyst events, roadshows and more

RLAY
Today at 08:00

Relay Therapeutics Firm Sponsored Meetings

Virtual Meeting
THO
Today at 09:00

Thor Industries Firm Sponsored Meetings

Airstream Headquarters, Jackson Center, OH
Today at 09:00

Technology/EV Supply Chain Industry Meetings
QRTEA
Today at 09:30

Qurate Retail Firm Sponsored Meetings

Virtual Meeting
NPSNY
Today at 10:00

Naspers - NPSNY Conference Calls
Today at 10:00

Consumer Industry Meetings
UTHR
Today at 10:30

United Therapeutics Corporation Firm Sponsored Meetings
DELL
Today at 10:30

Dell Technologies Inc. CL C Firm Sponsored Meetings
ORGN
Today at 11:00

Origin Materials Inc. Firm Sponsored Meetings
NTAP
Today at 11:30

NetApp - NTAP Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	IE X IE Ivanhoe Electric IPO Managers: BMO Capital & Jefferies, JPMorgan, Raymond James, RBC Capital, Scotiabank $11.75-12.50 14.388M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TUYA X TUYA Tuya Secondary Managers: CICC, BofA, Morgan Stanley & CMBI $2.30 7.3M Shares
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Zeta Global's Disqus, Akismet sign multi-year partnership to fight spam

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access